Sanofi
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
Last updated:
Abstract:
A compound of formula (I) as defined herein, or a pharmaceutically acceptable salt thereof, being potent modulators of human TNF.alpha. activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
Status:
Application
Type:
Utility
Filling date:
15 Feb 2021
Issue date:
19 Aug 2021